Natalia Chernyak and Vladimir Gevorgyan
FULL PAPERS
120.39 (+), 119.64 (+), 117.23 (+), 21.48 (+); HR-MS (EI):
m/z=336.1128, calcd. for C22H15F3: 336.1126.
9-(4-Methylbenzylidene)-1,3-bis(trifluoromethyl)-9H-fluo-
rene (2k): 1H NMR (400 MHz, CDCl3): d=8.22 (s, 1H),
8.16 (s, 1H), 7.90 (s, 1H), 7.78 (d, J=7.60 Hz, 1H), 7.39–
7.48 (m, 3H), 7.32–7.39 (m, 1H), 7.27–7.32 (m, 2H), 7.12 (s,
1H), 2.46 (s, 3H); 13C NMR (101 MHz, CDCl3): d=142.7
(s), 139.2 (s), 138.8 (s), 138.0 (s), 138.0 (s), 137.9 (s), 137.8
(s), 137.2 (s), 133.9 (s), 133.8 (s), 129.5 (s), 128.9 (s), 128.5
(s), 128.2 (s), 124.8 (s), 122.4 (s), 121.8 (s), 119.7 (s), 119.6
(s), 21.5 (s); HR-MS (EI): m/z=404.0998, calcd. for
C23H14F6: 404.1000.
Ethyl
(2E)-(1,3-difluoro-9H-fluoren-9-ylidene)acetate
(2e): 1H NMR (500 MHz, CDCl3): d=8.83 (d, J=7.89 Hz,
1H), 7.61 (d, J=7.34 Hz, 1H), 7.41–7.46 (m, 1H), 7.36–7.40
(m, 1H), 7.16 (dd, J=7.79, 2.11 Hz, 1H), 7.09 (d, J=
4.03 Hz, 1H), 4.35 (q, J=7.15 Hz, 2H), 1.40 (t, J=7.15 Hz,
3H); 13C NMR (126 MHz, CDCl3): d=166.3, 165.4, 163.3,
161.1, 159.1, 144.6, 140.5 (+), 135.8 (+), 130.6 (+), 129.2
(+), 128.8 (+), 120.0 (+), 119.3 (+), 103.4–103.9, 103.2 (+),
60.9 (+), 14.3 (+); HR-MS (EI): m/z=286.0813, calcd. for
C17H22F2O2: 286.0806.
9-(4-Nitrobenzylidene)-9H-fluorene
(2l):[25]
1H NMR
(400 MHz, CDCl3): d=8.32 (s, 2H), 7.66–7.85 (m, 5H), 7.60
(s, 1H), 7.42 (s, 2H), 7.35 (s, 2H), 7.07 (t, J=7.53 Hz, 1H);
13C NMR (101 MHz, CDCl3): d=147.2, 144.0, 141.8, 139.5,
138.9, 138.9, 135.8, 130.2 (+), 129.5 (+), 129.1 (+), 127.3
(+), 127.0 (+), 124.3 (+), 123.9 (+), 120.6 (+), 120.1 (+),
119.8 (+); HR-MS (EI): m/z=300.1025, calcd. for
C20H13NO2: 300.1025.
(9E)-4-Fluoro-1-methyl-9-(4-methylbenzylidene)-9H-fluo-
rene (2f): 1H NMR (500 MHz, CDCl3): d=7.93 (d, J=
7.52 Hz, 1H), 7.83 (s, 1H), 7.40 (s, 3H), 7.29 (s, 3H), 6.92–
7.10 (m, 3H), 2.68 (s, 3H), 2.46 (s, 3H); 13C NMR
(126 MHz, CDCl3): d=158.14 (+), 156.17 (+), 138.45
(+), 138.32 (+), 137.91 (+), 136.72 (+), 134.49 (s, 1C),
133.22 (+), 131.39 (s, 1 C), 131.34 (s, 1 C), 129.91 (s, 1 C),
129.56 (s, 1 C), 129.35 (s, 1 C), 128.95 (s, 1 C), 128.42 (s, 1
C), 126.42 (s, 1 C), 124.39 (s, 1 C), 114.48 (s, 1 C), 114.32 (s,
1 C), 21.81 (s, 1 C), 21.42 (s, 1 C); HR-MS (EI): m/z=
300.1313, calcd. for C22H17F: 300.1314.
(9E)-1,3-Difluoro-9-(4-methylbenzylidene)-9H-fluorene
(2g): 1H NMR (500 MHz, CDCl3): d=7.98 (d, J=2.75 Hz,
1H), 7.67 (d, J=7.52 Hz, 1H), 7.56 (d, J=7.89 Hz, 1H),
7.45 (d, J=7.89 Hz, 2H), 7.32 (dt, J=7.52, 0.92 Hz, 1H),
7.28 (s, 1H), 7.24 (dd, J=7.98, 2.11 Hz, 1H), 7.12 (dd, J=
15.22, 1.10 Hz, 1H), 6.78 (dt, J=11.00, 9.17, 2.20 Hz, 1H),
2.45 (s, 3H); 13C NMR (500 MHz, CDCl3): d=162.8 (dd, J=
248.8, 11.1 Hz), 159.4 (dd, J=253.4, 12.9 Hz), 142.9, 139.6,
138.2, 137.4 (+), 134.0 (+), 133.5 (+), 129.8 (+), 129.3 (+),
129.0 (+), 128.3 (+), 127.8 (+), 124.6 (+), 121.5 (+), 120.1
(+), 10.8 (+), 21.4 (+); HR-MS (EI): m/z=305.1142, calcd.
for C21H14F2: 305.1151.
4-(E)-[1,3-Bis(trifluoromethyl)-9H-fluoren-9-ylidene]me-
thylbenzonitrile (2h): 1H NMR (500 MHz, CDCl3): d=8.1
(d, J=13.9 Hz), 7.9 (s), 7.8 (s), 7.6–7.7 (m), 7.4 (s), 7.0–7.2
(m); 13C NMR (126 MHz, CDCl3): d=143.19, 141.74, 138.55,
138.24, 136.47, 135.92, 134.17, 132.64 (+), 129.53 (+), 129.39
(+), 128.56 (+), 124.81 (+), 122.09 (+), 120.17 (+), 119.84
(+), 118.51 (+), 112.33 (+), 91.16 (+); HR-MS (EI): m/z=
415.0798, calcd. for C23H11F6N: 415.0795.
(9Z)-3-(Trifluoromethyl)-9-[4-(trifluoromethyl)benzyli-
dene]-9H-fluorene (2i): 1H NMR (500 MHz, CDCl3): d=
7.94 (br. s., 1H), 7.82 (d, J=7.34 Hz, 1H), 7.72–7.79 (m,
4H), 7.68 (s, 2H), 7.45–7.51 (m, 2H), 7.38–7.45 (m, 1H),
7.34 (s, 1H); 13C NMR (126 MHz, CDCl3): d=141.9, 140.1,
138.8, 139.4, 138.1, 137.0, 130.6 (+), 129.5 (+), 129.1 (+),
128.1 (+), 127.3, 125.7 (+), 124.4 (+), 123.7 (+), 123.1,
122.9, 121.0 (+) 120.6 (+), 116.7 (+); HR-MS (EI): m/z=
390.0841, calcd. for C22H12F6: 390.0843.
4-(9H-Fluoren-9-ylidenemethyl)phenyl
methyl
ether
(2m):[25] 1H NMR (500 MHz, CDCl3): d=7.79 (d, J=
7.52 Hz, 1H), 7.73 (s, 3H), 7.66 (s, 1H), 7.56 (d, J=8.44 Hz,
2H), 7.29–7.42 (m, 3H), 7.10 (t, J=7.61 Hz, 1H), 7.00 (d,
J=8.80 Hz, 2H), 3.90 (s, 3H); 13C NMR (126 MHz, CDCl3):
d=159.56, 141.11, 139.70, 138.97, 136.64, 135.48, 130.87 (+),
129.12, 128.29 (+), 127.89 (+), 127.34 (+), 126.89 (+),
126.59 (+), 124.19 (+), 120.08 (+), 119.70 (+), 119.53 (+),
113.95 (+), 55.36 (+); HR-MS (EI): m/z=284.1202, calcd.
for C21H16O: 284.1201.
Methyl
(9E)-9-benzylidene-9H-fluorene-2-carboxylate
1
(2n): H NMR (400 MHz, CDCl3): d=8.48 (s, 1H), 8.09 (d,
J=8.04 Hz, 1H), 7.72–7.89 (m, 3H), 7.62 (s, 2H), 7.30–7.56
(m, 3H), 7.15 (s, 1H), 3.98 (s, 3H); 13C NMR (101 MHz,
CDCl3): d=167.3, 143.2, 140.1, 139.5, 137.5, 136.5 (+), 135.6
(+), 129.7 (+), 129.3 (+), 128.8 (+), 128.6 (+), 128.3 (+),
127.8 (+), 125.8, 124.5 (+), 121.7 (+), 120.6 (+), 120.4, 119.3
(+), 52.2 (+); HR-MS (EI): m/z=312.1149, calcd. for
C22H16O2: 312.1150.
3-(9H-Fluoren-9-ylidenemethyl)pyridine (2o): 1H NMR
(500 MHz, CDCl3): d=8.87 (s, 1H), 8.68 (dd, J=4.86,
1.38 Hz, 1H), 8.03 (s, 1H), 7.82 (d, J=7.89 Hz, 1H), 7.78 (d,
J=7.70 Hz, 1H), 7.67 (s, 2H), 7.48 (d, J=7.89 Hz, 1H), 7.43
(dd, J=7.89, 4.95 Hz, 1H), 7.39 (s, 1H), 7.12–7.18 (m, 1H);
13C NMR (126 MHz, CDCl3): d=150.1 (+), 149.4 (+), 142.3,
140.1, 139.2, 137.4, 136.7 (+), 136.4 (+), 132.3, 129.4 (+),
128.1 (+), 125.6, 124.4 (+), 124.3 (+), 123.4 (+), 120.7 (+),
119.8 (+), 117.5 (+); HR-MS (EI): m/z=323.09245, calcd.
for C20H13F3N: 323.09463.
(9E)-2-Fluoro-4-methyl-9-(4-methylbenzylidene)-9H-fluo-
rene (2p): 1H NMR (500 MHz, CDCl3): d=7.80 (d, J=
7.70 Hz, 1H), 7.68 (d, J=7.70 Hz, 1H), 7.61 (s, 1H), 7.48 (d,
J=7.89 Hz, 2H), 7.27–7.35 (m, 4H), 7.05 (s, 1H), 6.88 (s,
1H), 2.69 (s, 3H), 2.45 (s, 3H); 13C NMR (126 MHz,
CDCl3): d=162.1 (d, J=244.1 Hz), 141.5, 138.2, 137.1, 135.5,
134.6, 133.6, 133.1, 129.3 (d, J=8.3 Hz, +), 128.5 (+), 128.1
(+), 125.9, 125.6 (+), 124.1 (+), 122.4 (+), 117.2 (d, J=
22.2 Hz, +), 104.7 (d, J=23.1 Hz, +), 21.4 (+), 21.0 (+);
HR-MS (EI): m/z=305.1142, calcd. for C21H14F2: 305.1151.
(9E)-9-Benzylidene-1,3-difluoro-9H-fluorene
(2j):
1H NMR (500 MHz, CDCl3): d=8.0 (d, J=2.9 Hz), 7.7 (d,
J=7.7 Hz), 7.5 (s), 7.4–7.5 (m), 7.3 (s), 7.2 (s), 7.1 (s), 6.7–
6.8 (m); 13C NMR (126 MHz, CDCl3): d=139.66, 137.31,
137.03, 134.07, 133.14, 133.04, 128.98 (+), 128.58 (+), 128.45
(+), 128.21 (+), 128.15 (+), 127.93 (+), 127.83 (+), 124.67
(+), 120.14 (+), 103.09 (+), 102.88 (+), 102.74 (+), 102.53;
HR-MS (EI): m/z=290.09019, calcd. for C20H12F2:
290.09071.
(9E)-9-Benzylidene-1,4-dimethyl-9H-fluorene
(2q):
1H NMR (500 MHz, CDCl3): d=7.86 (s, 2H), 7.51 (s, 2H),
7.43–7.48 (m, 2H), 7.40 (s, 1H), 7.29 (s, 2H), 7.06 (s, 2H),
6.97 (s, 1H), 2.71 (s, 6H); 13C NMR (126 MHz, CDCl2): d=
141.7, 139.0, 138.2, 137.9, 137.6, 136.5, 131.5 (+), 131.5,
1110
ꢁ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2009, 351, 1101 – 1114